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Although Huntington’s disease (HD) is a neurodegenerative
disease characterized by motor, cognitive and behavioural disturbances,
there has been little empirical data examining what patients are
most concerned about throughout the different stages of disease, which can
span many years. Semi-structured face-to-face interviews were individually
conducted with 31 people living with different stages of Huntington’s,
from pre-clinical gene carriers to advanced stage. We examined
how often participants raised issues and concerns regarding the impact
of Huntington’s on everyday life. The Physical/functional theme hardly
featured pre-clinically, but was strongly present from Stage 1, rose steadily
and peaked at Stage 5. There were no signiﬁcant changes between stages
for the Emotional, Social, and Self themes that all featured across all
stages, indicating that these issues were not raised more frequently over the
course of the disease. Likewise, the more rarely mentioned Financial and
Legal themes also remained similar across stages. However, the Cognitive
theme only featured between Stages 1 and 4, and hardly at all pre-clinically
and at Stage 5. These ﬁndings provide insight into patients’ important
and unique perspective and have implications for the management
and development of interventions across the spectrum of HD stages.
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Huntington’s disease (HD) is a hereditary auto-
somal dominant neurodegenerative disease for
which direct mutation predictive testing has been
available since 1993. Although the motor, cog-
nitive and behavioural disturbances associated
with HD have been well documented in the
literature, there is little empirical data examining
how this translates into what patients themselves
are concerned about throughout the long course
of disease. The profound impact on patients’
physical and also psychosocial well-being (1, 2)
has been showed through data from generic quality
of life questionnaires. While these generic mea-
sures are useful, they also arbitrarily constrain the
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information provided, and hence limit our knowl-
edge of patients’ experience of living with this
complex disease. Interview studies which allow
patients to freely describe the impact of disease
play an important role in providing a meaning-
ful understanding of patients’ perspective on their
own well-being. The accumulating body of qual-
itative interview research in HD has focussed on
speciﬁc topics or speciﬁc patient subgroups (3, 4).
Information on the everyday impact of HD and
patient experiences at different stages of HD is
scarce. This study seeks to investigate how HD
affects the experience of everyday life in order to
understand what types of issues are at the forefront
of patients’ minds, and how the proﬁle of concerns
may evolve throughout the full trajectory of illness
from pre-clinical to end-stage HD.
Methods
Participants
Eighty individuals from pre-clinical status
(Pre-HD) to late-stage HD were invited to partici-
pate; 31 people volunteered within the time frame
of the study and provided consented to partici-
pate. Pre-HD individuals were HD mutation carri-
ers identiﬁed by the predictive test who reported
that they have not yet been given a diagnosis of
manifest HD. The entire clinical disease spectrum
was represented, and operationalized according to
self-reported Shoulson and Fahn (5) severity stag-
ing, ranging from Stage 1 (i.e. able to function at
home and work) to Stage 5 (i.e. require full-time
caring and nursing). All participants were from
the UK and comprised Pre-HD (3), Stage 1 (5),
Stage 2 (5), Stage 3 (3), Stage 4 (9) and Stage 5
(6) individuals; 67.7% were females, 32.3% males,
61.3% were aged between 30 and 59 years, and
38.7% between 60 and 89 years.
Data collection and analysis
Semi-structured interviews were conducted at par-
ticipants’ homes and lasted approximately 60 min.
Interview questions were standardized using open-
ended questions, followed by probes. These probes
addressed areas indicated by the health-related
quality of life concept as deﬁned by emotional
well-being, spirituality, sexuality, social function-
ing, family life, occupational functioning, commu-
nication, eating, functional ability, physical status,
treatment satisfaction, self-esteem, body image,
future orientation, global ratings of health and
life satisfaction (6). Pictorial topic cards were also
used to facilitate the interview process and sup-
port communication with Stage 5 participants since
this has been shown to be useful in previous
research (7). Interviews were recorded, transcribed
verbatim, and classiﬁed according to themes that
emerged, i.e. (i) Physical/functional, (ii) Cogni-
tion, (iii) Emotion, (iv) Social, (v) Self, (vi) Legal
and (vii) Financial. Detailed qualitative analysis of
interview narratives was beyond the scope of this
brief report.
In this study, the number of times each par-
ticipant mentioned speciﬁc instances where HD
had a negative impact on their lives was classiﬁed
according to the seven themes. For each partici-
pant, the frequency with which they raised issues
relating to each theme in interview was summed
according to theme and then divided by the total
number of reports across all themes to be expressed
as a percentage frequency for each speciﬁc theme.
In order for meaningful comparisons to be made
across different disease stages, the percentage fre-
quency of reporting each theme was then averaged
across the number of participants in each stage of
disease. Therefore, Fig. 1 shows the average per-
centage frequency of participants’ raising of each
theme for each disease stage.
Results and discussion
As shown in Fig. 1, most of the issues raised by
pre-HD participants fell into the Social theme (i.e.
family relationships in the context of HD, dissatis-
faction with Huntington’s services, lack of support
(family, friends, health professionals, and commu-
nity), and others’ perceived attitude to HD and
lack of awareness regarding Huntington’s), fol-
lowed by the Emotional theme (i.e. anxiety regard-
ing the impact of Huntington’s on the family and
also themselves in terms of emerging HD signs
and symptoms). Some of these latter concerns res-
onated with the Self theme (i.e. acceptance of HD,
self-conﬁdence, independence, and especially ful-
ﬁlling personal wishes). Legal issues were raised
less frequently than other themes, but seemed to
feature strongly in pre-HD relative to other stages,
as the implications of the disease led to mak-
ing appropriate arrangements up front, particularly
regarding insurance. Physical/functional and Cog-
nitive issues hardly featured at all in pre-HD.
In Stage 1, Physical activities and functional
ability (i.e. difﬁculty in sleeping well, swallow-
ing food and drink, and experiencing twitches
and jerks), Cognitive issues (e.g. difﬁculty in con-
centrating, organizing, deciding, slower in getting
things done, and particularly difﬁculty in remem-
bering everyday information), Emotional issues
(low mood, low motivation, and particularly anxi-
ety about the emergence of signs and symptoms
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Fig. 1. Average frequency (%) for each theme according to Huntington’s disease stage.
associated with HD) were frequently reported.
Social (complicated family relationships in the
context of HD, lack of support and awareness of
HD from those around them, as well as concerns
regarding going out to socialize) and Self (fulﬁlling
personal wishes and changes in self-conﬁdence)
themes also appeared.
For Stage 2 participants, Physical/functional
(i.e. swallowing food and drink, sleeping well,
driving performance, maintaining a stable body
weight, changes with balance, walking, clarity of
speech pronunciation, and writing ability), Emo-
tional (i.e. low mood, low motivation, anxiety
about signs and symptoms associated with HD,
losing patience, mood swings, and worries regard-
ing the impact of Huntington’s on the family),
Cognition (i.e. difﬁculty in remembering everyday
information, organizing daily activities, changes in
spoken language expression, ability to learn new
things and multitasking), Social (complicated fam-
ily relationships in the context of HD, going out
for social occasions, maintaining sexual relation-
ships, others’ attitude to HD and lack of aware-
ness regarding Huntington’s, and dissatisfaction
with Huntington’s services) and Self (i.e. fulﬁll-
ing personal wishes, changes in self-conﬁdence,
embarrassment and being self-conscious) themes
featured. The Financial theme (mainly issues sur-
rounding change or loss of employment) occurred
less frequently, and occurred even less in subse-
quent stages.
In Stages 3 and 4, the Physical/functional
theme (i.e. sleeping well, swallowing, tiredness,
speech pronunciation, walking, stair climbing and
handling objects, driving, balance, chorea, slow-
ness, dressing, washing and slowness, and also
incontinence in the latter stage) was more dom-
inant than other themes of Cognition (i.e. concen-
trating, remembering everyday information, slow
to get things done, making decisions, spoken lan-
guage expression, learning new things and time
orientation), Emotion (i.e. anxiety over HD signs
and symptoms, low motivation, for the latter stage
low mood and mood swings, and anxiety regarding
the impact of Huntington’s on the family), Social
(key issues at Stage 3 were regarding going out for
social occasions, others’ attitude to HD and lack
of awareness regarding Huntington’s, and main-
taining sexual relationships; and at Stage 4, inef-
fective communication, others’ attitude to HD and
lack of awareness regarding Huntington’s, family
relationships in the context of HD, lack of sup-
port from family, friends, and health professionals,
going out to socialize occasions and maintaining
sexual relationships), and Self (i.e. reduced con-
ﬁdence, independence, fulﬁlling personal wishes,
feeling embarrassed or self-conscious, and for the
latter stage the acceptance of HD in one’s life).
The dominance of the Physical/functional theme
(i.e. key issues were ambulation, and swallowing;
also raised was feeling tired and sleeping well,
issues regarding maintaining body weight, clar-
ity of speech, movement control, and writing and
dressing) was clear in Stage 5, while the Cogni-
tive theme hardly featured. Low mood was the
most frequently raised Emotional aspect in Stage
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5, with only a few individuals mentioning low
motivation, feeling angry and worrying about HD
symptoms. The key Social issue for most Stage 5
participants was the lack of support from family,
friends and health professionals. Like other stages,
the Self theme was represented mainly by issues
with self-conﬁdence, self-consciousness, and per-
sonal wishes.
Using Kruskal–Wallis nonparametric one-way
anova, the effect of stage was examined for each
theme. The occurrence of Emotion, Social, Self,
Finance and Legal themes were not signiﬁcantly
different between groups, however the Physi-
cal/functional (H(5) = 12.70, p < 0.05) and cog-
nitive (H(5) = 11.40, p < 0.05) themes showed
signiﬁcant differences. Post hoc analyses showed
that for the Physical/functional theme, there was
a signiﬁcant difference between pre-HD and Stage
1( U = 0.00, p < 0.05), but not for consecutive
groups at subsequent stages, and only a trend
between Stage 1 and Stage 5 (U = 5.00, p <
0.07). This indicates that there was a signiﬁcant
increase in Physical/functional issues at Stage 1,
and this then remains equally high after this, with
no real signiﬁcant increase between each subse-
quent severity stage. For the Cognitive theme,
there was a mild trend for an increase between
the pre-HD and Stage 1 group (U = 2.00, p <
0.09), with no signiﬁcant differences between sub-
sequent stages, until Stage 4 which was signiﬁ-
cantly greater than Stage 5 (U = 7.50, p < 0.05).
Thus, there was a ﬂat inverted U curve with Cog-
nitive issues appearing from Stage1 and remaining
at a similar low level of occurrence until Stage 5,
where they dissipated.
Conclusion
Our frequency of patient mention data provide
unique insight into the impact and concerns of a
wide range of patients, and the different trajec-
tories of development across the different themes
over the course of HD. There appeared to be
four phases of HD marked by different proﬁles
of HD impact, which synchronize with and corre-
spond coherently with key HD-related milestones.
During the pre-HD stage, participants were pre-
occupied with internal and relational issues; these
Emotional, Social and Self concerns remained
throughout the subsequent stages of HD and
did not increase. In the early stage of manifest
HD (Stages 1 and 2), often marked by clini-
cal diagnosis and practical consequences of dis-
ease, participants’ comments frequently revolve
around Physical/functional and Cognitive issues,
in recognition and perhaps also adaptation to
the emergence of concrete HD symptoms. Dur-
ing moderate HD (Stages 3 and 4), there was
least change in the state of play for the vari-
ous thematic proﬁles; therefore from the patients’
perspective, this appeared to be a period of sta-
bility in the overall scheme of disease progres-
sion. Because of the very gradual, but inexorable
increase in Physical/functional concerns, late-stage
HD (Stage 5), was characterized predominantly by
this theme, and the lack of Cognitive concerns
most likely due to degree of cognitive impair-
ment which affects insight (8), while internal and
relational (Emotional, Social and Self) themes per-
sisted without much change throughout the preced-
ing severity stages. In Parkinson’s disease another
protracted neurodegenerative disease, physical and
social aspects of health-related quality of life,
although not cognitive, were found to deteriorate
over time in a 4-year longitudinal study (9). The
physical and functional aspect was also dominant
in Alzheimer’s disease (10).
One of this study’s limitations is the cross-
sectional design, which nevertheless served to pro-
vide for the ﬁrst time a snap-shot of concerns in a
wide spectrum of patients. Furthermore, qualitative
scrutiny of participants’ detailed comments, out-
side of the scope of this report, will certainly sup-
plement the perspective gained by the current anal-
ysis. It may also be relevant to consider the data
in the context of age since more severely affected
patients tend to be older than presymptomatic and
mild patients due to the protracted course of the
disease. Our sample also comprised more women
than men, and it is not clear if gender might differ-
entially affect health-related quality of life in HD.
In Parkinson’s disease, it is worth noting, however,
that men and women are no different (11).
In summary, this study provides for the ﬁrst
time, an overview of the proﬁle of HD impact
throughout the full trajectory of illness from pre-
clinical to end-stage HD, from patients’ unique
and important perspective. Information regarding
phases of change and stability over the protracted
course of the disease will be of interest to
clinicians, researchers and patients. It also provides
an informed basis for the long-term management of
health and well-being in HD, and the development
of interventions across the spectrum of HD stages.
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